E-LIB Suche - Ergebnisse für: Matulonis, Ursula

1

Phase I/II Study of Combined BCL-xL and MEK Inhibition with..:

Corcoran, Ryan B. ; Do, Khanh T. ; Kim, Jeong E....
Clinical Cancer Research. 30 (2024) 9 - p. 1739-1749 , 2024

Link: https://doi.org/10.1158/..

2

Experiences of patients with peritoneal carcinomatosis-rela..:

Pozzar, Rachel A. ; Wall, Jaclyn A. ; Tavormina, Anna...
Gynecologic Oncology. 181 (2024) - p. 68-75 , 2024

Link: https://doi.org/10.1016/..

3

Benchmarking mismatch repair testing for patients with canc..:

Bou Farhat, Elias ; Adib, Elio ; Daou, Melissa...
Cancer Cell. 42 (2024) 1 - p. 6-7 , 2024

Link: https://doi.org/10.1016/..

4

Phase 1b study of mirvetuximab soravtansine, a folate recep..:

Richardson, Debra L. ; Moore, Kathleen N. ; Vergote, Ignace...
Gynecologic Oncology. 185 (2024) - p. 186-193 , 2024

Link: https://doi.org/10.1016/..

5

Combined aromatase, CDK4/6 and PI3K blockade using letrozol..:

Konstantinopoulos, Panagiotis A. ; Xiong, Niya ; Krasner, Carolyn...
Gynecologic Oncology Reports. 52 (2024) - p. 101348 , 2024

Link: https://doi.org/10.1016/..

6

Benchmarking mismatch repair testing for patients with canc..:

Bou Farhat, Elias ; Adib, Elio ; Daou, Melissa...
Cancer Cell. 42 (2024) 2 - p. 323 , 2024

Link: https://doi.org/10.1016/..

7

A phase 2 trial exploring the significance of homologous re..:

Liu, Joyce F. ; Xiong, Niya ; Wenham, Robert M....
Gynecologic Oncology. 187 (2024) - p. 105-112 , 2024

Link: https://doi.org/10.1016/..

8

Genetic and pharmacologic dependency upon anti-apoptotic pr..:

Stover, Elizabeth ; Shay, Brendan ; Matulonis, Ursula..
Gynecologic Oncology. 176 (2023) - p. S164-S165 , 2023

Link: https://doi.org/10.1016/..

9

Molecular determinants of clinical outcomes of pembrolizuma..:

Ledermann, Jonathan A. ; Shapira-Frommer, Ronnie ; Santin, Alessandro D....
Gynecologic Oncology. 178 (2023) - p. 119-129 , 2023

Link: https://doi.org/10.1016/..

10

Mirvetuximab soravtansine (MIRV) in patients with platinum-..:

Coleman, Robert ; Oaknin, Ana ; Pignata, Sandro...
Gynecologic Oncology. 176 (2023) - p. S3 , 2023

Link: https://doi.org/10.1016/..

11

Transforming ovarian cancer care by targeting minimal resid..:

Jazaeri, Amir A. ; Grisham, Rachel ; Knisely, Anne...
Med. 4 (2023) 11 - p. 755-760 , 2023

Link: https://doi.org/10.1016/..

12

Safety and efficacy of mirvetuximab soravtansine, a folate ..:

Gilbert, Lucy ; Oaknin, Ana ; Matulonis, Ursula A....
Gynecologic Oncology. 170 (2023) - p. 241-247 , 2023

Link: https://doi.org/10.1016/..

13

STING agonism overcomes STAT3-mediated immunosuppression an..:

Ding, Liya ; Wang, Qiwei ; Martincuks, Antons...
Journal for ImmunoTherapy of Cancer. 11 (2023) 1 - p. e005627 , 2023

Link: https://doi.org/10.1136/..

14

Botensilimab, a novel innate/adaptive immune activator, plu..:

Bockorny, Bruno ; Matulonis, Ursula ; O'Day, Steven...
Gynecologic Oncology. 176 (2023) - p. S35-S36 , 2023

Link: https://doi.org/10.1016/..

15

Final overall survival and long-term safety in the ENGOT-OV..:

Matulonis, Ursula ; Herrstedt, Jørn ; Oza, Amit...
Gynecologic Oncology. 176 (2023) - p. S31-S32 , 2023

Link: https://doi.org/10.1016/..